Founded in 1992, Metabolix is an innovative company seeking sustainable solutions for the plastic industry. With capabilities in advanced scientific knowledge, Metabolix integrated our biotechnology research with real world application. Now, Metabolix is focusing on the use of Mirel® PHA biopolymers as an alternative to PVC and PLA. We hope to develop a more effective and efficient solution for the industry.
Funding Rounds (2) - $31MUpdate
Current Team (7)Update
Vice President, Business and Commercial Development, Biopolymers
Vice President of Marketing and Corporate Communications
President and CEO
Chief Scientific Officer, Vice President, Research
Vice President, Biobased Chemicals
Due to the growing demand of traditional plastic, Metabolix Biopolymers became a sustainable alternative to meet the performance.
Metabolix’s modifiers can be used as performance additives for PVC and PLA to improve the performance without taking biobased content away.
Metabolix converts their own biobased material into applications to understand the functional biodegradation in different circumstances.
Metabolix PHA technology is a platform for developing renewable chemicals, which can be applied to C2 to C6 chemicals.
Metabolix developed a genetic engineering system for different plant crops, such as switchgrass and oilseeds, to increase PHB production.
Metabolix’s process is price competitive and that developing and commercializing C3 renewable chemicals represents another attractive
Metabolix has developed a proprietary and cost effective direct route for producing renewable GBL and has demonstrated that GBL can also be
|Aug 24, 2016||google.com - Radical Transformation At Metabolix, Inc. (NASDAQ:MBLX)?|
|Jul 29, 2016||Business Wire - Global Biodegradable Plastics Market Research Report 2016 - Industry Analysis, Size, Share, Growth, Trends and Forecast 2015-2022 - Research and Markets|
|Jun 3, 2016||Mass Device - Tepha buys its way out of Metabolix bioresorbables deal|
|Jun 3, 2016||Mass Device - Noxilizer wins 510(k) for NO2 sterilization of medical device|
|Jun 1, 2016||PRNewswire UK All - Global Bio-Based Platform Chemicals Market is Expected to Reach $18.8 Billion, by 2021|
|Jun 1, 2016||Mass Device - Phillips-Medisize buys drug-delivery-device focused developer Medicom|
|Dec 18, 2015||Business Wire - Research and Markets: Biodegradable Plastics Market 2015-2021 - Key Driving Factors for this Market are Government Regularities for Waste Dispose and its Management|
|Dec 9, 2015||PRNewswire All - Biopolymers/Bioplastics Market: Favored By New Trends & Policies|
21 Erie Street
Cambridge, Massachusetts 02139
Biopolymers Group office
650 Suffolk Street
Lowell, Massachusetts 01854